Why Fate Therapeutics Stock Is Sliding Today
What happened
Shares of Fate Therapeutics(NASDAQ:FATE), a clinical-stage biotechnology company, are sliding in response to interim data from ongoing clinical trials with two of its new drug candidates. Investors unimpressed with the company’s new approach…
